Pipeline · public log
What we are researching next.
The pipeline is public. Each item lists the questions the chapter tries to answer and how many sources we have read so far. Items move from queued → in research → in draft → published as the literature comes together.
03
In research
01
In draft
04
Queued
P
In research
- 01Lipohypertrophy, recognition, prevention, and what it actually feels like under the skin
- What is the published prevalence in patients on long-term subcutaneous therapy?
- Which rotation patterns measurably reduce incidence?
- How do you distinguish lipohypertrophy from a benign lump on palpation?
4 sources read - 02Reconstitution of multi-vial compounds, math, sterility, and storage windows
- How does benzyl alcohol concentration affect the storage window once a vial is breached?
- What does the published literature say about pooling vials of the same compound?
3 sources read - 03Travel. TSA rules, refrigeration logistics, and the practical edge cases
- What is the current TSA guidance on injectable medications and ice packs?
- How long can a refrigerated pen sit at room temperature before potency is in question?
6 sources read
D
In draft
- 01Sharps disposal, what counts as compliant in each US state
- Which states accept curbside disposal in approved containers?
- Where do mail-back programs make sense for at-home injectors?
2 sources read
Q
Queued
- 01Pen-injector failures, when the pen clicks but no medication delivers
- 02Subcutaneous vs intramuscular, when each is indicated, and the consequence of getting it wrong
- 03Cold-chain failure, what to do when a refrigerator fails overnight with a pen inside
- 04Pediatric administration, the gauge, length, and angle differences for under-18 injectors